Xtx Topco LTD Codexis, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.59 - $4.65 $140,789 - $252,769	-54,359 Reduced 77.76%	15,551 $54,000
Q4 2023 Feb 13, 2024	SELL	$1.54 - $3.37 $187,190 - $409,630	-121,552 Reduced 63.49%	69,910 $213,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.75 $130,726 - $326,816	87,151 Added 83.55%	191,462 $361,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $40,126 - $80,435	-18,157 Reduced 14.83%	104,311 $292,000
Q1 2023 May 12, 2023	SELL	$3.81 - $6.76 $132,290 - $234,720	-34,722 Reduced 22.09%	122,468 $507,000
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $547,192 - $878,591	128,449 Added 446.92%	157,190 $732,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $174,170 - $369,609	28,741 New	28,741 $174,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.